|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on May 03, 2023 |
Title |
Exposure to a bacterial metabolite induces specific transcriptional signature of DAF-16 regulated genes, xanthine oxidase, and Phase I detoxification enzymes in C. elegans |
Organism |
Caenorhabditis elegans |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
RNA-seq analysis of the effect of a secondary metabolite produced by Streptomyces venezuelae that enhanced oxidative stress, mitochondrial dysfunction, and neurodegeneration in Caenorhabditis elegans. Nearly all DEGs had previous evidence of an association with DAF-16 (FOXO). DEGs were also enriched for Phase I (CYP) and Phase II (UGT) detoxification genes. DEGs representing several non-CYP Phase I enzymes were identified, including down-regulation of xdh-1. XDH-1 is interconvertible with XO and S. ven metabolite exposure enhanced XO activity.
|
|
|
Overall design |
Comparative gene expression profiling analysis of RNA-seq data for C. elegans exposed to the S.ven metabolite or an ethyl acetate solvent control, 5 biological replicates.
|
|
|
Contributor(s) |
Thies JL, Willicott K, Craig ML, Greene MR, DuGay CN, Caldwell GA, Caldwell KA |
Citation |
https://0-doi-org.brum.beds.ac.uk/10.3390/cells12081170
|
Submission date |
Nov 04, 2022 |
Last update date |
May 03, 2023 |
Contact name |
Guy Caldwell |
E-mail(s) |
gcaldwel@ua.edu
|
Organization name |
The University of Alabama
|
Department |
Biological Sciences
|
Street address |
300 Hackberry Lane
|
City |
Tuscaloosa |
State/province |
AL |
ZIP/Postal code |
35487 |
Country |
USA |
|
|
Platforms (1) |
GPL22765 |
Illumina HiSeq 4000 (Caenorhabditis elegans) |
|
Samples (20)
|
GSM6710673 |
BY250 strain, S.ven treatment, day 5, rep1 |
GSM6710674 |
BY250 strain, S.ven treatment, day 5, rep2 |
GSM6710675 |
BY250 strain, S.ven treatment, day 5, rep3 |
GSM6710676 |
BY250 strain, S.ven treatment, day 5, rep4 |
GSM6710677 |
BY250 strain, S.ven treatment, day 5, rep5 |
GSM6710678 |
BY250 strain, EtAc treatment, day 5, rep1 |
GSM6710679 |
BY250 strain, EtAc treatment, day 5, rep2 |
GSM6710680 |
BY250 strain, EtAc treatment, day 5, rep3 |
GSM6710681 |
BY250 strain, EtAc treatment, day 5, rep4 |
GSM6710682 |
BY250 strain, EtAc treatment, day 5, rep5 |
GSM6710683 |
BY250 strain, S.ven treatment, day 7, rep1 |
GSM6710684 |
BY250 strain, S.ven treatment, day 7, rep2 |
GSM6710685 |
BY250 strain, S.ven treatment, day 7, rep3 |
GSM6710686 |
BY250 strain, S.ven treatment, day 7, rep4 |
GSM6710687 |
BY250 strain, S.ven treatment, day 7, rep5 |
GSM6710688 |
BY250 strain, EtAc treatment, day 7, rep1 |
GSM6710689 |
BY250 strain, EtAc treatment, day 7, rep2 |
GSM6710690 |
BY250 strain, EtAc treatment, day 7, rep3 |
GSM6710691 |
BY250 strain, EtAc treatment, day 7, rep4 |
GSM6710692 |
BY250 strain, EtAc treatment, day 7, rep5 |
|
Relations |
BioProject |
PRJNA898366 |
Supplementary file |
Size |
Download |
File type/resource |
GSE217300_Metabolite_Differentially_Expressed_Genes_D5.xlsx |
2.5 Mb |
(ftp)(http) |
XLSX |
GSE217300_Metabolite_Differentially_Expressed_Genes_D7.xlsx |
2.5 Mb |
(ftp)(http) |
XLSX |
GSE217300_Metabolite_Readcount_D5.xlsx |
2.2 Mb |
(ftp)(http) |
XLSX |
GSE217300_Metabolite_Readcount_D7.xlsx |
2.2 Mb |
(ftp)(http) |
XLSX |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|